Markets:

Overview

News

Currencies

International

Treasuries

CorMedix Inc. - Common Stock (NQ:CRMD)

7.930 +0.430 (+5.73%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CorMedix Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

CorMedix (CRMD) Q1 2026 Earnings Transcript ↗

Today 14:44 EDT

CorMedix (CRMD) Q1 2026 Earnings Transcript

Via The Motley Fool

CorMedix Q1 Earnings Call Highlights ↗

Today 10:07 EDT

CorMedix (NASDAQ:CRMD) reported sharply higher first-quarter 2026 revenue and profit, driven by continued adoption of DefenCath and the addition of products from its Melinta acquisition, while...

Via MarketBeat

Topics Earnings

CorMedix Inc (NASDAQ:CRMD) Surges After Blowout Q1 Earnings Beat and Raised Guidance ↗

Today 8:23 EDT

Via Chartmill

Topics Earnings

CorMedix (CRMD) Q4 2025 Earnings Call Transcript ↗

March 05, 2026

CorMedix (CRMD) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

CorMedix Inc (NASDAQ:CRMD) Shares Drop on Q4 2025 Earnings Miss ↗

March 05, 2026

Via Chartmill

CorMedix Inc (NASDAQ:CRMD) Exemplifies a High-Growth Stock Screen Methodology ↗

January 20, 2026

Via Chartmill

CorMedix Stock Breaks Out To 2-Month High: Analysts Reset Price Targets After Blowout Q3 And Surging DefenCath Demand ↗

November 13, 2025

Via Stocktwits

Why Did CRMD Stock Tumble Over 11% Today? ↗

March 05, 2026

The company reported mixed Q4 results with a revenue of $128.6 million and earnings per share of $0.16.

Via Stocktwits

Topics Artificial Intelligence

High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 ↗

January 19, 2026

Via MarketBeat

Nasdaq, S&P 500 Futures Pause Ahead Of Jobs Report, Trump Tariff Ruling: Why OPEN, INTC, NVDA, TLRY, CRMD, GLUE Are On Traders' Radar Today ↗

January 09, 2026

Via Stocktwits

Topics Government Stocks

CorMedix Stock Rises After-Hours: CEO Locks In Chairman Seat, Bigger Paycheck And Rich Severance ↗

January 08, 2026

Joseph Todisco’s annual base salary increases to $750,000 from $665,000, effective Jan. 1.

Via Stocktwits

Here are the top movers in Thursday's session. ↗

January 08, 2026

Via Chartmill

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

Why Did CRMD Stock Crash 28% Today? ↗

January 08, 2026

CorMedix announced that for 2026, it expects revenue between $300 million and $320 million, compared to $310 million it reported in the full year 2025, according to preliminary data.

Via Stocktwits

These stocks are gapping in today's session ↗

January 08, 2026

Via Chartmill

CorMedix Inc (NASDAQ:CRMD): A Textbook Fit for a High-Growth Stock Screener ↗

December 29, 2025

CorMedix (CRMD) exemplifies a high-growth stock with explosive sales, strong earnings momentum, and robust profitability, fitting a proven investment framework.

Via Chartmill

Why CorMedix Could be the Biopharma Name to Watch Early in 2026 ↗

December 23, 2025

Via MarketBeat

MarketBeat’s Top 5 Rated Small-Cap Stocks ↗

December 22, 2025

Via MarketBeat

Why Is CorMedix Stock Rising Today? ↗

December 18, 2025

CorMedix said that its catheter lock solution showed fewer catheter-related bloodstream infections and secondary hospitalizations in adult dialysis patients in the interim study.

Via Stocktwits

CorMedix Inc (NASDAQ:CRMD) Shows Explosive Growth Metrics in "Little Book" Screen ↗

December 08, 2025

CorMedix (CRMD) shows explosive sales & earnings growth, strong momentum, and a surprisingly low valuation, making it a top growth stock candidate.

Via Chartmill

Talphera (TLPH) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

Talphera (TLPH) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

CorMedix Q3 Profit Soars As DefenCath Dialysis Demand Exceeds Expectations ↗

November 12, 2025

CorMedix posts strong Q3 results with $104 million in revenue, higher DefenCath sales, and raises 2025 guidance following Melinta integration progress.

Via Benzinga

Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday ↗

November 12, 2025

Via Benzinga

Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance ↗

November 12, 2025

The company now expects pro forma net revenue for the full year in a range of $390 million to $410 million, higher than a Wall Street estimate of $283.66 million.

Via Stocktwits

Topics Earnings

CorMedix Inc. (NASDAQ:CRMD) Q3 2025 Earnings: Revenue Beat Offsets EPS Miss ↗

November 12, 2025

CorMedix Inc. (CRMD) Q3 2025 earnings show a revenue beat of $104.3M, but an EPS miss. The stock rose in pre-market trading on strong sales growth.

Via Chartmill

CorMedix Inc (NASDAQ:CRMD) Fulfills Key Growth Stock Criteria from The Little Book ↗

November 11, 2025

CorMedix (CRMD) excels in a proven growth stock strategy, showing massive sales growth, strong earnings momentum, and solid profitability metrics.

Via Chartmill

Top Stocks With Earnings This Week: Plug, Oklo, Circle And More ↗

November 10, 2025

Here's a look at this week's earnings reports that are most likely to be watched by retail investors, including Oklo, Plug and Circle.

Via Benzinga

Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 22, 2025

From Halper Sadeh LLC

Via Business Wire

Beyond The Numbers: 4 Analysts Discuss Cormedix Stock ↗

October 21, 2025

Via Benzinga

CorMedix Inc (NASDAQ:CRMD) Fits a Proven Growth Strategy with Strong Fundamentals ↗

October 21, 2025

CorMedix Inc. fits a proven growth investing strategy with explosive revenue growth, soaring profits, and strong analyst revisions, signaling high potential.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.